Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) CFO Matthew Buckhalter sold 11,188 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $5.72, for a total transaction of $63,995.36. Following the completion of the transaction, the chief financial officer now directly owns 490,057 shares of the company's stock, valued at $2,803,126.04. This trade represents a 2.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Aveanna Healthcare Trading Down 1.9%
Aveanna Healthcare stock traded down $0.10 during trading hours on Friday, reaching $4.98. 131,408 shares of the stock were exchanged, compared to its average volume of 324,110. The stock has a 50 day moving average of $5.09 and a two-hundred day moving average of $4.92. The company has a market cap of $971.76 million, a P/E ratio of -14.63 and a beta of 2.03. Aveanna Healthcare Holdings Inc. has a twelve month low of $2.32 and a twelve month high of $6.19.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on AVAH shares. Truist Financial decreased their price objective on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a report on Friday, April 11th. UBS Group boosted their price objective on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research report on Friday, May 9th.
View Our Latest Analysis on Aveanna Healthcare
Institutional Investors Weigh In On Aveanna Healthcare
A number of institutional investors have recently added to or reduced their stakes in the business. Jacobs Levy Equity Management Inc. boosted its stake in Aveanna Healthcare by 50.1% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company's stock worth $2,437,000 after acquiring an additional 177,856 shares in the last quarter. Northern Trust Corp grew its stake in shares of Aveanna Healthcare by 11.3% during the 4th quarter. Northern Trust Corp now owns 478,907 shares of the company's stock worth $2,189,000 after acquiring an additional 48,572 shares during the period. Charles Schwab Investment Management Inc. grew its position in shares of Aveanna Healthcare by 0.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company's stock valued at $2,133,000 after purchasing an additional 4,047 shares in the last quarter. First Eagle Investment Management LLC bought a new stake in Aveanna Healthcare during the fourth quarter valued at $1,992,000. Finally, Millennium Management LLC increased its holdings in shares of Aveanna Healthcare by 105.0% in the 4th quarter. Millennium Management LLC now owns 400,374 shares of the company's stock worth $1,830,000 after buying an additional 205,023 shares during the last quarter. 87.96% of the stock is owned by institutional investors.
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
See Also

Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.